The research could eventually lead to new sources of organs for transplant, but ethical and technical hurdles need to be overcome. Read more in nature.com
Category Archives: News
After several high-profile cases, the country’s government is creating a board to oversee and investigate all serious allegations of scientific misconduct. Read more in the-scientist.com
Scary new life-threatening fungal infections could soon menace mankind, thanks to climate change, a new report argues. Read more in webmd.com
On 25th July 2018, the Court of Justice of the European Union ruled that the regulatory framework for genetic engineering should be extended to recently developed methods of gene editing. The European Federation of Biotechnology regrets this ruling because it ignores scientific arguments that the interpretations of the technologies are scientifically inaccurate. Read more on […]
The devastating outbreak of the disease that has led to millions of pig deaths in East Asia has intensified efforts to develop a vaccine quickly, but the virus presents several challenges that are yet to be overcome. Read more in the-scientist.com
Researchers have used CRISPR, the genome editing tool, to speed the inheritance of specific genes in mammals for the first time. Read more in sciencemag.org
The Pentagon has been asked to examine whether ticks and other insects were experimented on as potential biological weapons, after a US politician demanded the US military give answers. Read more in telegraph.co.uk
The cancer fighters known as CAR T cells have proved their prowess in recent years. Three therapies using the altered T cells against lymphoma or leukemia have won U.S. Food and Drug Administration approval, and hundreds of trials are now unleashing them on other malignancies, including solid tumors. Read more in sciencemag.org
Researchers use two techniques—Wolbachia infection and irradiation—to suppress reproduction in populations of Asian tiger mosquitoes at two study sites in China. Read more in the-scientist.com
Today, Batavia Biosciences announces it received a follow-up grant of $2.2 million from PATH – a global organization dedicated to health equity – to develop and manufacture novel oral poliovirus vaccines (nOPV). Read more in bataviabiosciences.com